Intent-to-Treat vs. Non-Intent-to-Treat Analyses under Treatment Non-Adherence in Mental Health Randomized Trials.

FULL DISCLOSURE POLICY In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears at the beginning of each CME-accredited article in this issue.

[1]  Xihong Lin,et al.  A Comparison of Methods for Estimating the Causal Effect of a Treatment in Randomized Clinical Trials Subject to Noncompliance , 2009, Biometrics.

[2]  J. Dungan.  Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin , 2009 .

[3]  Kevin G Lynch,et al.  A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention. , 2008, Alcoholism, clinical and experimental research.

[4]  J. Manson,et al.  Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. , 2008, JAMA.

[5]  Sebastian Schneeweiss,et al.  Preference-Based Instrumental Variable Methods for the Estimation of Treatment Effects: Assessing Validity and Interpreting Results , 2007, The international journal of biostatistics.

[6]  Graham Dunn,et al.  Modelling treatment‐effect heterogeneity in randomized controlled trials of complex interventions (psychological treatments) , 2007, Statistics in medicine.

[7]  T. T. Have,et al.  An introduction to causal modeling in clinical trials , 2007, Clinical trials.

[8]  N. Duan,et al.  Is some provider advice on smoking cessation better than no advice? An instrumental variable analysis of the 2001 National Health Interview Survey. , 2006, Health services research.

[9]  J. Robins,et al.  Instruments for Causal Inference: An Epidemiologist's Dream? , 2006, Epidemiology.

[10]  Peter B. Jones,et al.  Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. , 2005, Schizophrenia bulletin.

[11]  Michelle Meadows,et al.  Genomics and personalized medicine. , 2005, FDA consumer.

[12]  A James O'Malley,et al.  Likelihood Methods for Treatment Noncompliance and Subsequent Nonresponse in Randomized Trials , 2005, Biometrics.

[13]  S. Normand,et al.  Improving traditional intention-to-treat analyses: a new approach , 2005, Psychological Medicine.

[14]  Deborah Gross,et al.  A Critical Analysis of the Intent-to-Treat Principle in Prevention Research , 2004, Journal of Primary Prevention.

[15]  Michael R Elliott,et al.  Causal Models for Randomized Physician Encouragement Trials in Treating Primary Care Depression , 2004 .

[16]  Robert D. Gibbons,et al.  Estimating the Efficacy of Receiving Treatment in Randomized Clinical Trials with Noncompliance , 2001, Health Services and Outcomes Research Methodology.

[17]  M. Salzer,et al.  The conflict between random assignment and treatment preference: implications for internal validity. , 2003, Evaluation and program planning.

[18]  J. Coyne,et al.  Research to improve the quality of care for depression: alternatives to the simple randomized clinical trial. , 2003, General hospital psychiatry.

[19]  H. Kraemer,et al.  Mediators and moderators of treatment effects in randomized clinical trials. , 2002, Archives of general psychiatry.

[20]  J. Teresi,et al.  Some Statistical Issues in the Analyses of Data From Longitudinal Studies of Elderly Chronic Care Populations , 2002, Psychosomatic medicine.

[21]  Alvan R. Feinstein,et al.  Principles of Medical Statistics , 2001 .

[22]  R. Prinz,et al.  Recruitment and retention of participants in prevention trials involving family-based interventions. , 2001, American journal of preventive medicine.

[23]  L. Fogg,et al.  Threats to validity in randomized clinical trials. , 2000, Research in nursing & health.

[24]  S. Hollis,et al.  What is meant by intention to treat analysis? Survey of published randomised controlled trials , 1999, BMJ.

[25]  G. Livingston,et al.  Drug treatment of older people with affective disorders in the community: lessons from an attempted clinical trial , 1999, International Journal of Geriatric Psychiatry.

[26]  J. Lave,et al.  Treating major depression in primary care practice. Eight-month clinical outcomes. , 1996, Archives of general psychiatry.

[27]  David A. Jaeger,et al.  Problems with Instrumental Variables Estimation when the Correlation between the Instruments and the Endogenous Explanatory Variable is Weak , 1995 .

[28]  D. Machin,et al.  Intention to treat--who should use ITT? , 1993, British Journal of Cancer.

[29]  Wayne Katon,et al.  Adequacy and Duration of Antidepressant Treatment in Primary Care , 1992, Medical care.

[30]  P W Lavori,et al.  Clinical trials in psychiatry: should protocol deviation censor patient data? , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[31]  H. Ireys,et al.  Who enrolls in prevention trials? Discordance in perception of risk by professionals and participants , 1991, American journal of community psychology.

[32]  S. Zeger,et al.  On estimating efficacy from clinical trials. , 1991, Statistics in medicine.

[33]  A. B. Hill,et al.  Principles of Medical Statistics , 1950, The Indian Medical Gazette.